Lorlatinib Renal Impairment Study
Clinical trial NCT03542305 · COMPLETED
Trial details
- NCT number
- NCT03542305
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2020-02-20
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.